(1)
Paller, A.; Eichenfield, L.; Silverberg, J.; Cork, M.; Bangert, C.; Irvine, A.; Weidinger, S.; Barbarot, S.; Fan, H.; Alderfer, J.; Koppensteiner, H.; Chittuluru, K. Integrated Safety Analysis of Abrocitinib in 635 Adolescent Patients With Moderate-To-Severe Atopic Dermatitis With Over 1000 Patient-Years of Exposure. J of Skin 2024, 8, s379.